(Pien Huang/ NPR) — It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop severe illness.

Now, researchers from the Veterans Health Administration find that taking the medication may also reduce  …

(Megan DeLaire/ CTV News) -Pfizer’s antiviral medication Paxlovid is designed to reduce the risk of hospitalization in patients with COVID-19, and it’s approved for use across Canada.

Although it has the potential to take some pressure off hospitals during coronavirus surges, some doctors and pharmacists believe   …

(Ryan Tumilty/ The National Post) — Health Canada has approved Pfizer’s drug Paxlovid as the first take-home treatment for COVID-19.

The drug, which is a treatment involving a total of six pills taken daily for five days, has been shown to reduce the risk of hospitalization by almost 90 per cent. The course of treatment includes  …

(The Associated Press/ CBC News) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials  …